Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly.


Journal

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
ISSN: 1439-4286
Titre abrégé: Horm Metab Res
Pays: Germany
ID NLM: 0177722

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 6 9 2019
medline: 15 2 2020
entrez: 6 9 2019
Statut: ppublish

Résumé

The purpose of the study was to compare serum visfatin levels between patients with acromegaly and healthy controls and to evaluate the relationships between visfatin levels and epicardial fat thickness (EFT), carotid intima media thickness (cIMT), and ankle brachial index (ABI). We conducted a cross-sectional case-control study of 54 patients with acromegaly (37 females and 17 males) and 34 healthy controls (22 females and 12 males). Serum visfatin was measured by ELISA. Acromegalic and control participants and those with active or controlled acromegaly were compared with respect to their serum visfatin, clinical and metabolic parameters, EFT, cIMT, and ABI. Linear correlation was used to identify associations between these parameters and visfatin in all participants. Serum visfatin and glycated hemoglobin (HbA1c) were higher in the acromegaly group than in the control group (p

Identifiants

pubmed: 31487747
doi: 10.1055/a-0998-4079
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Cytokines 0
Glycated Hemoglobin A 0
IGF1 protein, human 0
hemoglobin A1c protein, human 0
Human Growth Hormone 12629-01-5
Insulin-Like Growth Factor I 67763-96-6
Nicotinamide Phosphoribosyltransferase EC 2.4.2.12
nicotinamide phosphoribosyltransferase, human EC 2.4.2.12

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

649-654

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Hamide Piskinpasa (H)

Department of Endocrinology and Metabolism, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Yildiz Okuturlar (Y)

Department of Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Sema Ciftci Dogansen (SC)

Department of Endocrinology and Metabolism, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Yasemin Sefika Akdeniz (YS)

Department of Endocrinology and Metabolism, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Ayse Esen (A)

Department of Endocrinology and Metabolism, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Sogol Sadri (S)

Department of Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Osman Pirhan (O)

Department of Cardiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Aysegul Akdogan Gemici (AA)

Department of Radiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Sibel Ocak Serin (SO)

Department of Internal Medicine, Umraniye Training and Research Hospital, Istanbul, Turkey.

Asuman Gedikbası (A)

Department of Biochemistry, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Mine Adas (M)

Department of Internal Medicine, Okmeydani Training and Research Hospital, Istanbul, Turkey.

Meral Mert (M)

Department of Endocrinology and Metabolism, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH